Rutgers, The State University of New Jersey Listed a New Clinical Trial of Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients with Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

Press/Media: Press / Media

PeriodAug 17 2017

Media coverage

1

Media coverage

  • TitleRutgers, The State University of New Jersey Listed a New Clinical Trial of Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients with Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer
    Media name/outletIndia Pharma News
    CountryIndia
    Date8/17/17
    PersonsSalma Jabbour